Whereas AQP1 (stages I + II and III + IV), AQP4 (stages I + II and III + IV), and AQP5 (stage I + II) expressions revealed remarkably unfavorable OS in all ovarian cancer patients. This evidence concerns the gene AQP5 and ovarian cancer.